Genomic rearrangements associated with-5/del(5q) and-7/del(7q) in myeloid leukemias

被引：0
|
作者：
Tennant, Thelma R. [1 ]
Huo, Dezheng [2 ]
Davis, Elizabeth M. [1 ]
Larson, Richard A. [1 ]
Le Beau, Michelle M. [1 ]
机构：
[1] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1813
引用
收藏
页码：537A / 537A
页数：1
相关论文
共 50 条
  • [21] Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis
    Beth A. Pitel
    Neeraj Sharma
    Cinthya Zepeda-Mendoza
    James B. Smadbeck
    Kathryn E. Pearce
    Joselle M. Cook
    George Vasmatzis
    Zohar Sachs
    Rashmi Kanagal-Shamanna
    David Viswanatha
    Sheng Xiao
    Robert B. Jenkins
    Xinjie Xu
    Nicole L. Hoppman
    Rhett P. Ketterling
    Jess F. Peterson
    Patricia T. Greipp
    Linda B. Baughn
    Blood Cancer Journal, 11
  • [22] Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): Clinicopathologic comparison of del(5q)-positive and -negative cases
    Santana-Davila, Rafael
    Tefferi, Ayalew
    Holtan, Shernan G.
    Ketterling, Rhett P.
    Dewald, Gordon W.
    Knudson, Ryan A.
    Steensma, David P.
    Chen, Dong
    Hoyer, James D.
    Hanson, Curtis A.
    LEUKEMIA RESEARCH, 2008, 32 (12) : 1927 - 1930
  • [23] β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q)
    Li, Liping
    Sheng, Yue
    Li, Wenshu
    Hu, Chao
    Mittal, Nupur
    Tohyama, Kaoru
    Seba, Amber
    Zhao, You-Yang
    Ozer, Howard
    Zhu, Tongyu
    Qian, Zhijian
    CANCER RESEARCH, 2017, 77 (15) : 4116 - 4126
  • [24] Del(5q): gene dosage matters
    Walter, Matthew J.
    BLOOD, 2007, 110 (02) : 473 - 474
  • [25] DBA, del(5q): a reciprocal relationship
    Ellis, Steven R.
    BLOOD, 2011, 118 (08) : 2032 - 2033
  • [26] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [27] Lenalidomide in AML: Del(5q) or who?
    Steensma, David P.
    Stone, Richard M.
    BLOOD, 2011, 118 (03) : 481 - 482
  • [28] Fluorescence In Situ Hybridization (FISH) Testing for-5/5q,-7/7q,+8, and del(20q) in Primary Myelodysplastic Syndrome (MDS) Is Unnecessary in the Setting of an Adequate Conventional Cytogenetic Study
    Pitchford, Clovis W.
    Hettinga, Ana C.
    Reichard, Kaaren K.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (04) : 623 - 623
  • [29] Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia
    Eldfors, Samuli
    Saad, Joseph
    Ikonen, Nemo
    Malani, Disha
    Vaha-Koskela, Markus
    Gjertsen, Bjorn T.
    Kontro, Mika
    Porkka, Kimmo
    Heckman, Caroline A.
    BLOOD ADVANCES, 2024, 8 (07) : 1621 - 1633
  • [30] A MINIMAL INTERVAL FOR DEL(5Q) IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA
    HORRIGAN, SK
    WESTBROOK, CW
    KIM, AH
    STOCK, W
    LARSON, RA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 351 - 351
12345